Inhibition of the Oxidative Modification of LDL by Nitecapone
- 1 June 1995
- journal article
- research article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 15 (6) , 740-747
- https://doi.org/10.1161/01.atv.15.6.740
Abstract
We studied in vitro the ability of nitecapone, 3-[(3,4-dihydroxy-5-nitrophenyl)methylene]-2,4-pentanedione, a novel water-soluble compound with antioxidative properties, to inhibit the LDL...Keywords
This publication has 48 references indexed in Scilit:
- The role of lipids and antioxidative factors for development of atherosclerosis: The Probucol Quantitative Regression Swedish Trial (PQRST)The American Journal of Cardiology, 1993
- Antioxidant properties of nitecapone (OR-462)Free Radical Biology & Medicine, 1992
- Evidence for an additional intracellular site of action of probucol in the prevention of oxidative modification of low density lipoprotein. Use of a new water-soluble probucol derivative.Journal of Clinical Investigation, 1992
- The oxidative modification of low density lipoprotein by human lymphocytesAtherosclerosis, 1992
- Role of lipoprotein-copper complex in copper catalyzed-peroxidation of low-density lipoproteinBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1992
- β-Carotene inhibits the oxidative modification of low-density lipoproteinBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1991
- The physiological role of zinc as an antioxidantFree Radical Biology & Medicine, 1990
- Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man.Journal of Clinical Investigation, 1989
- Beyond CholesterolNew England Journal of Medicine, 1989
- THE DISTRIBUTION AND CHEMICAL COMPOSITION OF ULTRACENTRIFUGALLY SEPARATED LIPOPROTEINS IN HUMAN SERUMJournal of Clinical Investigation, 1955